Clinical Trial Now Enrolling for Patients with Dilated Cardiomyopathy (DCM) due to Genetic Mutations or Unknown Causes Bristol Myers Squibb is conducting a clinical trial in patients with DCM due to genetic mutations or unknown causes. Details of the study and eligibility requirements are listed below and participating in such research can help advance therapies
Clinical Trials
Myths and Truths About Clinical Trials
Please click on this link or the image above to view a recording of this webinar and learn about: Myths and Truths About Clinical Trials Industry experts discuss the Myths and Truths of Clinical Trials on a panel discussion Learn about the phases and average timeline for clinical trials Hear about the measures taken to ensure
Clinical Trial Now Enrolling for Patients with Genetic DCM (MYH7)
Dilated cardiomyopathy, DCM, has many causes and can be acquired or genetic. Genetic means a disease-causing change, or “mutation”, has occurred in a relevant gene. That mutation may have occurred in prior generations or may be new as just having happened in a patient 1,2. This type of DCM is called genetic DCM. Research
Read More… from Clinical Trial Now Enrolling for Patients with Genetic DCM (MYH7)